key: cord-0261053-j83jabfz authors: Zekavat, S. M.; Honigberg, M.; Pirruccello, J.; Kohli, P.; Karlson, E. W.; Newton-Cheh, C.; Zhao, H.; Natarajan, P. title: Influence of blood pressure on pneumonia risk: Epidemiological association and Mendelian randomisation in the UK Biobank date: 2020-04-23 journal: nan DOI: 10.1101/2020.04.19.20071936 sha: 92e41573def43680b92c175cbadf422409b8f0dd doc_id: 261053 cord_uid: j83jabfz Objectives: To determine whether elevated blood pressure influences risk for respiratory infection. Design: Prospective, population-based epidemiological and Mendelian randomisation studies. Setting: UK Biobank. Participants: 377,143 self-identified British descent (54% women; median age 58 years) participants in the UK Biobank. Main outcome measures: First incident pneumonia over an average of 8 follow-up years. Results: 107,310 (30%) participants had hypertension at UK Biobank enrolment, and 9,969 (3%) developed a pneumonia during follow-up. Prevalent hypertension at baseline was significantly associated with increased risk for incident respiratory disease including pneumonia (hazard ratio 1.36 (95% confidence interval 1.29 to 1.43), P<0.001), acute respiratory distress syndrome or respiratory failure (1.43 (1.29 to 1.59), P<0.001), and chronic lower respiratory disease (1.30 (1.25 to 1.36), P<0.001), independent of age, age2, sex, smoking status, BMI, prevalent diabetes mellitus, prevalent coronary artery disease, and principal components of ancestry. Mendelian randomisation analyses indicated that genetic predisposition to a 5 mmHg increase in blood pressure was associated with increased risk of incident pneumonia for SBP (1.08, (1.04 to 1.13), P<0.001) and DBP (1.11 (1.03 to 1.20), P=0.005). Additionally, consistent with epidemiologic associations, increase in blood pressure genetic risk was significantly associated with reduced forced expiratory volume in the first second, forced vital capacity, and the ratio of the two (P<0.001 for all). Conclusions: These results strongly suggest that elevated blood pressure independently increases risk for pneumonia and reduces pulmonary function. Maintaining adequate blood pressure control, in addition to other measures, may reduce risk for pneumonia. Whether the present findings are generalizable to novel coronavirus disease 2019 (COVID-19) require further study. Hypertension is a highly prevalent, modifiable risk factor for cardiovascular disease and 3 mortality 1 . Epidemiologic analyses have correlated hypertension with pneumonia risk in small 4 studies 2 3 . Whether this represents a direct consequence of hypertension or influence of co-5 morbid risk factors such as age, diabetes mellitus, air pollution, or smoking is unclear. Hypertension has emerged as one of the most well-recognized risk factors for developing novel 8 coronavirus disease 2019 (COVID-19) from SARS-CoV-2 infection [4] [5] [6] [7] . In particular, patients with 9 COVID-19 who develop acute respiratory distress syndrome (ARDS) are particularly enriched 10 for hypertension 7 . Angiotensin converting enzyme (ACE) is an endogenous regulator of blood 11 pressure that is highly expressed in the lung and has been linked to risk for acute respiratory 12 distress syndrome (ARDS) 8 9 . ACE2, a homolog and endogenous counter-regulator of ACE, is 13 expressed in a subset of type II alveolar cells and is an important facilitator of cell entry by 14 SARS-CoV-2 [8] [9] [10] . ACE2 has also been implicated in lung injury related to other respiratory 15 viruses and bacterial pathogens [11] [12] [13] . While professional societies have encouraged patients to 16 remain on ACE inhibitors during the present pandemic, recommendations were largely made in 17 the absence of robust human data. Although epidemiologic analyses support a plausible causal relationship between blood 20 pressure regulation and respiratory infection risk, confounding from comorbid conditions limit 21 such inference. Importantly, comorbid factors such as advanced age, diabetes mellitus, and 22 cardiovascular disease have also been described as independent risk factors for pneumonia 23 previously as well as for COVID-19. Mendelian randomisation is a statistical approach using 24 genetic proxies for an exposure as opposed to the exposure itself to mitigate risks for 25 confounding facilitating more robust causal inference 14 . Blood pressure is a highly heritable trait 26 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 23, 2020. . https://doi.org /10.1101 /10. /2020 with several known associated genomic loci that may serve as a robust aggregated genetic 1 proxy for Mendelian randomization 15 . In the UK Biobank prior to the COVID-19 pandemic, we (1) estimate the epidemiologic 4 association of hypertension with incident pneumonia risk and indices of pulmonary function, and (2) apply Mendelian randomisation to test the hypothesis that blood pressure independently 6 causally influences risks for pneumonia and reduced pulmonary function. British ancestry consenting to genetic analyses, with genotypic-phenotypic sex concordance, 20 without sex aneuploidy, and one from each pair of 1 st or 2 nd degree relatives selected randomly. Participants provided informed consent as previously described. Secondary use of the data was . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 23, 2020. 16 . Variants used in the 4 present analysis include those also imputed using the Haplotype Reference Consortium 5 reference panel of up to 39 million single nucleotide polymorphisms (SNPs) 17 18 . Poor quality 6 variants and genotypes were filtered as previously described 16 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 23, 2020. . https://doi.org /10.1101 /10. /2020 Patients taking at least one ACEi were included in the ACEi category, patients taking no ACEi 1 but at least one ARB were included in the ARB category, and patients who reported that they 2 were taking a blood pressure medication (via UK Biobank Field IDs 6153 and 6177) but were 3 not taking an ACEi or ARB were included in the 'other' category. and accounting for skewness in the phenotypic data identified using the Robustbase package in 10 R (setting range=3) (https://cran.r-project.org/web/packages/robustbase/robustbase.pdf). Phenotypes were then inverse rank normalized to mean 0 and standard deviation (SD) 1 for CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 23, 2020. . https://doi.org/10.1101/2020.04.19.20071936 doi: medRxiv preprint Genetic instruments for blood pressure and association analyses 1 One-sample Mendelian randomisation was performed in the UK Biobank by associating inverse-2 rank normalized systolic blood pressure and diastolic blood pressure polygenic risk scores (SBP 25 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 23, 2020. Association analysis of the SBP and DBP PRS with incident respiratory diseases was 1 performed using Cox proportional hazards models in R (version 3.5, R Foundation, Vienna, 2 Austria), adjusting for age, age 2 , sex, smoking status, and the first ten principal components of 3 ancestry. The proportional hazards assumption was assessed by Schoenfeld residuals and was 4 satisfied. Association analyses between the SBP and DBP PRS and pulmonary function tests 5 was performed using a generalized linear model adjusted for the same covariates. Association of the 75 variants for each PRS with both prevalent and incident pneumonia was 8 performed using a logistic regression Wald test in Hail-0.2, adjusting for age, age 2 , sex, smoking 9 status, the first ten principal components of ancestry, and genotype array. Using these 10 associations, two-sample Mendelian randomization was performed using the ICBP-derived SBP CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 23, 2020. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 23, 2020. (Figure 2) . However, upon further adjustment for prevalent hypertension status, we did not 7 observe an association of these medication classes with risk for pneumonia. Genetic association of blood pressure with incident respiratory disease 10 11 We first used one-sample Mendelian randomisation to determine whether a genetic 12 predisposition to increased blood pressure is associated with increased risk for incident 13 pneumonia as well as other respiratory diseases. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 23, 2020. . https://doi.org/10.1101/2020.04.19.20071936 doi: medRxiv preprint sweet intake, significant life stressor in the past two years, or exercise frequency 1 (Supplemental Table 7 ). Each SD increase in the SBP PRS was associated with a significant increased risk of incident suggesting that no single SNP drives the observed association (Supplementary Figure 1) . . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 23, 2020. In a large, prospective, population-based cohort, we show that prevalent hypertension is a risk 24 factor for incident pneumonia, lower respiratory infections, ARDS or respiratory failure, as well 25 as many other respiratory diseases. Additionally, our epidemiological analyses also 26 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 23, 2020. . demonstrate an association between prevalent hypertension and increased pulmonary 1 obstruction as indicated by reduced FEV1/FVC. Our Mendelian randomisation studies imply that 2 the relationship between increased blood pressure with increased risk for pneumonia as well as 3 reduced pulmonary function may be causal. ACEi may be protective for pneumonia risk 42 . As detailed earlier, since ACE2 may serve as a 25 receptor for respiratory viral entry and is an endogenous counter-regulator of ACE, conflicting 26 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 23, 2020. Thus, withdrawal of ACEi and challenges of blood pressure management while promoting 12 physical distancing, may not only have untoward cardiovascular consequences but may 13 inadvertently increase pneumonia risk. Strengths and limitations 16 17 This study has several strengths, including the analysis of a large, genotyped population-based 18 cohort with high fidelity phenotyping, including with subclinical respiratory phenotypes. Furthermore, diverse phenotyping facilitates extensive individual-level covariate adjustment in 20 the models and sensitivity analyses to assess for pleiotropy. Our overall study design, with the CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 23, 2020. . https://doi.org/10.1101/2020.04.19.20071936 doi: medRxiv preprint association of the genetic instrument to the outcome occurs via the primary exposure and is not 1 confounded by pleiotropy 50 51 . We have performed a number of sensitivity analyses to assess for 2 possible confounders, in particular, we observe that our genetic instruments for blood pressure 3 are not associated with key socioeconomic and lifestyle factors influencing both blood pressure 4 and pneumonia risk. We further maintain a sparsely adjusted model in our one-sample 5 Mendelian randomization analyses to reduce the potential for collider bias 52 Our study provides evidence that hypertension directly influences the risk of pneumonia. Vigilance for blood pressure monitoring and management may reduce risk for pneumonia, including potentially for the ongoing COVID-19 pandemic. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 23, 2020. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 23, 2020. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 23, 2020. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 23, 2020. . . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 23, 2020. . https://doi.org/10.1101/2020.04.19.20071936 doi: medRxiv preprint . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 23, 2020. . https://doi.org/10.1101/2020.04.19.20071936 doi: medRxiv preprint A call to action and a lifecourse strategy to address the 3 global burden of raised blood pressure on current and future generations: the Lancet 4 Commission on hypertension Associations between untraditional risk factors, 7 pneumonia/lung cancer, and hospital fatality among hypertensive men in Guangzhou 8 downtown Reduction of risk of pneumonia associated with use of 11 angiotensin I converting enzyme inhibitors in elderly inpatients Clinical features of patients infected with 2019 novel 15 coronavirus in Wuhan, China Evolving Epidemiology and Impact of Non-pharmaceutical 18 Interventions on the Outbreak of Coronavirus Disease Clinical Features of 69 Cases with Coronavirus Disease Risk Factors Associated With Acute Respiratory Distress 24 Syndrome and Death in Patients With Coronavirus Disease ACE mediates ventilator-induced lung 28 injury in rats via angiotensin II but not bradykinin Angiotensin converting enzyme insertion/deletion 31 polymorphism is associated with susceptibility and outcome in acute respiratory distress 32 syndrome A crucial role of angiotensin converting enzyme 2 (ACE2) in 35 SARS coronavirus-induced lung injury Angiotensin-converting enzyme 2 (ACE2) mediates influenza 38 H7N9 virus-induced acute lung injury Angiotensin-converting enzyme 2 inhibits lung injury induced by 41 respiratory syncytial virus A Dynamic Variation of Pulmonary ACE2 Is 44 Required to Modulate Neutrophilic Inflammation in Response to Pseudomonas 45 aeruginosa Lung Infection in Mice Reading Mendelian randomisation studies: a 1 guide, glossary, and checklist for clinicians Genetic analysis of over 1 million 4 people identifies 535 new loci associated with blood pressure traits The UK Biobank resource with deep phenotyping 8 and genomic data A reference panel of 64,976 haplotypes for 11 genotype imputation Genetic Association of Finger 16 Photoplethysmography-Derived Arterial Stiffness Index With Blood Pressure Coronary Artery Disease Genome-wide association analysis identifies 20 novel blood pressure loci and offers biological insights into cardiovascular risk Adjusting for treatment effects in studies of 23 quantitative traits: antihypertensive therapy and systolic blood pressure Health and deprivation. Inequality and the North. 26 MendelianRandomization: an R package for performing 28 Mendelian randomization analyses using summarized data Robust instrumental variable methods using 31 multiple candidate instruments with application to Mendelian randomization Statistical inference in two-sample 35 summary-data Mendelian randomization using robust adjusted profile score Orienting the causal relationship between imprecisely 38 measured traits using GWAS summary data Genetic 41 effects on gene expression across human tissues Impact of pneumonia and lung cancer on mortality of women 44 with hypertension Role of the T cell in the genesis of angiotensin II 1 induced hypertension and vascular dysfunction Lysozyme M-positive monocytes mediate 4 angiotensin II-induced arterial hypertension and vascular dysfunction Circulating neutrophils maintain physiological blood 8 pressure by suppressing bacteria and IFNgamma-dependent iNOS expression in the 9 vasculature of healthy mice White Blood Cells and Blood Pressure: A Mendelian 12 Randomization Study Regulatory effects of iNOS on acute lung 15 inflammatory responses in mice Nox1 oxidase suppresses influenza a virus-18 induced lung inflammation and oxidative stress Decreased lung function is associated with increased 21 arterial stiffness as measured by peripheral pulse pressure: data from NHANES III Association of pulse wave velocity with total lung 25 capacity: A cross-sectional analysis of the BOLD London study Associations among lung function, arterial 29 elasticity, and circulating endothelial and inflammation markers: the multiethnic study of 30 atherosclerosis Cardiovascular comorbidity in COPD: systematic 33 literature review Genetic overlap of chronic obstructive pulmonary disease and 36 cardiovascular disease-related traits: a large-scale genome-wide cross-trait analysis Quantitative Dual-Energy Computed Tomography 40 Supports a Vascular Etiology of Smoking-induced Inflammatory Lung Disease Inflammatory mechanisms in patients with chronic obstructive pulmonary disease Risk of pneumonia associated with use of 1 angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic 2 review and meta-analysis Are patients with hypertension and diabetes mellitus at 5 increased risk for COVID-19 infection? Renin-Angiotensin-Aldosterone System 8 Inhibitors in Patients with Covid-19 Renin-Angiotensin System Blockers and the COVID-19 11 Pandemic: At Present There Is No Evidence to Boszhurt BKRHB. HFSA/ACC/AHA statement addresses concerns re: using RAAS 15 antagonists in COVID-19: AHA Science News Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and 19 Angiotensin Receptor Blockers: European Society of Cardiology A Randomized Trial of Intensive versus 23 Standard Blood-Pressure Control Association of Inpatient Use of Angiotensin Converting Enzyme 26 Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With 27 Hypertension Hospitalized With COVID-19 Mendelian randomization in cardiometabolic 30 disease: challenges in evaluating causality Mendelian randomisation in cardiovascular research: an 33 introduction for clinicians Genetic epidemiology and Mendelian 36 randomization for informing disease therapeutics: Conceptual and methodological 37 challenges